(Total Views: 200)
Posted On: 04/17/2023 11:35:54 AM
Post# of 128872

$XBIT News Article - XBiotech Announces First Subject Enrollment in Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke https://marketwirenews.com/news-releases/xbio...49009.html


My Twitter: WhyteStocks